Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    "gene therapy" OR "gene transfer" OR "virus delivery" | herpes
Show Display Options
Rank Status Study
1 Active, not recruiting Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Biological: herpes simplex thymidine kinase;   Drug: ganciclovir
2 Completed TK-based Suicide Gene Therapy for Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Genetic: TK99UN
3 Completed Gene Transfer for Cancer Pain
Condition: Cancer Pain
Intervention: Biological: NP2
4 Completed Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver
Conditions: Colorectal Cancer;   Metastatic Cancer
Intervention: Biological: NV1020
5 Completed ADV-TK Improves Outcome of Recurrent High-Grade Glioma
Conditions: Malignant Glioma of Brain;   Glioblastoma
Interventions: Biological: ADV-TK/GCV;   Procedure: Surgery;   Drug: systemic chemotherapy
6 Active, not recruiting rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors
Conditions: Liver Metastases;   Primary Liver Cancers
Intervention: Biological: administration of rRp450 into the hepatic artery
7 Recruiting HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: HSV-tk +Valacyclovir in Combination with Brachytherapy

Study has passed its completion date and status has not been verified in more than two years.